Report from IBS' Annual General Meeting: Improved Investment Climate in Several Markets
June 13, 2003 03:59 ET | IBS
STOCKHOLM, Sweden, June 13, 2003 (PRIMEZONE) -- At IBS' Annual General Meeting (AGM) on 12 June, 2003, CEO Magnus Wastenson stated that the investment climate is improving in several markets, e.g. in...
Cordiant Communications Group PLC
Cordiant Communications Group plc Announces a Posting Today Regarding Shareholder Approval
June 13, 2003 03:56 ET | Cordiant Communications Group PLC
LONDON, June 13, 2003 (PRIMEZONE) -- Cordiant Communications Group plc ("Cordiant") (NYSE:CDA) (LSE:CRI) announces that it is posting later today a circular to its shareholders seeking their approval...
New Appointments at SKF
June 13, 2003 03:21 ET | SKF
GOTEBORG, Sweden, June 13, 2003 (PRIMEZONE) -- Christer Gyberg, Executive Vice President AB SKF (Nasdaq:SKFR) and President Industrial Division, will take up the responsibility as President of the...
NCC Serves Notice to 195 Employees in Stockholm
June 13, 2003 03:05 ET | NCC
SOLNA, Sweden, June 13, 2003 (PRIMEZONE) -- Due to the downturn in the Stockholm office and housing market, NCC Construction Sweden is serving employment-termination notices to 150 craftsmen and 45...
Allied Irish Banks, p.l.c. Purchase Of Own Shares
June 13, 2003 02:08 ET | Allied Irish Banks, p.l.c.
DUBLIN, Ireland, June 13, 2003 (PRIMEZONE) -- Allied Irish Banks, p.l.c. ("AIB") (NYSE:AIB) announces that on 12 June 2003, it purchased 2,500,000 of its ordinary shares, at an average price of...
NOVARTIS logo.jpg
FDA approves Stalevo (TM) for treatment of Parkinson's disease
June 13, 2003 01:50 ET | Novartis Pharma AG
Stalevo contains levodopa, the most widely used agent for Parkinson's disease, pluscarbidopa and entacapone. While carbidopa reduces the side effects of levodopa,entacapone optimizes its benefits,...
Stalevo, Orion's new
Stalevo, Orion's new treatment for Parkinson's disease approved by the FDA
June 13, 2003 01:36 ET | Orion Oyj
Orion Pharma has received an approval from the US FDA  (Food and Drug Administration) for Stalevo, which combines levodopa and carbidopa with entacapone in one tablet for the treatment of...
Orionin uusi Parkins
Orionin uusi Parkinson-lääke Stalevo sai myyntiluvan Yhdysvalloissa
June 13, 2003 01:32 ET | Orion Oyj
Orion Pharma on saanut Yhdysvaltojen lääkeviranomaiselta, FDA:lta, myyntiluvan uudelle Parkinsonin taudin lääkkeelleen, Stalevolle. Lääke sisältää kolmea vaikuttavaa ainetta: levodopaa, karbidopaa...
Nokia has started commercial deliveries of the world's first dual-mode 3GPP compliant GSM/WCDMA mobile phone capable of seamless handovers
June 13, 2003 00:59 ET | Nokia Oyj
  Following the successful completion of the piloting and test program, Nokia has started shipments of the Nokia 6650 mobile phone to selected mobile operators and retailers in Europe and Asia,...
FSPS, Inc. and Iris Broadband, Inc. Agree to Unwind Merger
June 12, 2003 18:00 ET | Federal Security Protection Services Inc.
NEW ORLEANS, June 12, 2003 (PRIMEZONE) -- Federal Security Protection Services, Inc. ("FSPS") (OTCBB:FSPS) announced that the Board of Directors voted to reverse the tax-free stock exchange...